×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Can-Fite BioPharma (NYSE:CANF) Research Coverage Started at StockNews.com
Defense World
Read Can-Fite BioPharma (NYSE:CANF) Research Coverage Started at StockNews.com at Defense World.
7 hours ago
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on ...
KXAN Austin
ORLANDO, FL / ACCESSWIRE / May 10, 2024 / RedChip Companies will air interviews with Can-Fite BioPharma Ltd. (NYSE American:CANF) and...
6 days ago
Can-Fite receives FDA IND clearance for MASH treatment trial
Clinical Trials Arena
Can-Fite BioPharma obtained FDA IND clearance for a Phase IIb trial of Namodenoson to treat metabolic dysfunction-associated...
6 days ago
Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at ...
Business Wire
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
3 days ago
Can-Fite BioPharma Full Year 2023 Earnings: Revenues Disappoint
Simply Wall Street
Can-Fite BioPharma ( TLV:CANF ) Full Year 2023 Results Key Financial Results Net loss: US$7.63m (loss narrowed by 25...
1 month ago
Can-Fite BioPharma Advances ED Treatment Patent - TipRanks.com
Tipranks
Can-Fite BioPharma Ltd. has announced the European Patent Office's Notice of Allowance for CF602, a drug candidate for treating erectile...
1 week ago
The Anti-Obesity Effect of Can-Fite's Namodenoson: Molecular Mechanism of Action in Pre-clinical and Human Studies
Yahoo Finance
PETACH TIKVA, Israel, December 20, 2023--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a...
4 months ago
Can-Fite Reports 2023 Financial Results and Clinical Update
Business Wire
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
1 month ago
FDA grants Can-Fite BioPharma's Namodenoson IND clearance for NASH - TipRanks.com
Tipranks
Can-Fite BioPharma announces that the U.S. Food and Drug Administration FDA has granted Investigational New Drug IND clearance for...
6 days ago
Can-Fite submits paediatric study plan of psoriasis drug to FDA
Clinical Trials Arena
Can-Fite BioPharma has submitted a paediatric study plan to the US Food and Drug Administration (FDA) of anti-inflammatory drug...
8 months ago